These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24501341)

  • 1. Immune responses of Iranian patients with visceral leishmaniasis and recovered individuals to LCR1 of Leishmania infantum.
    Niknam HM; Abrishami F; Doroudian M; Rostamian M; Moradi M; Khaze V; Iravani D
    Clin Vaccine Immunol; 2014 Apr; 21(4):518-25. PubMed ID: 24501341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete conservation of an immunogenic gene (lcr1) in Leishmania infantum and Leishmania chagasi isolated from Iran, Spain and Brazil.
    Mahmoudzadeh-Niknam H; Abrishami F; Doroudian M; Moradi M; Alimohammadian MH; Parvizi P
    J Vector Borne Dis; 2010 Dec; 47(4):204-10. PubMed ID: 21178212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel Leishmania infantum recombinant antigen which elicits interleukin 10 production by peripheral blood mononuclear cells of patients with visceral leishmaniasis.
    Suffia I; Ferrua B; Stien X; Mograbi B; Marty P; Rousseau D; Fragaki K; Kubar J
    Infect Immun; 2000 Feb; 68(2):630-6. PubMed ID: 10639426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenicity of
    Fernández L; Carrillo E; Sánchez-Sampedro L; Sánchez C; Ibarra-Meneses AV; Jimenez MA; Almeida VDA; Esteban M; Moreno J
    Front Immunol; 2018; 9():843. PubMed ID: 29740446
    [No Abstract]   [Full Text] [Related]  

  • 6. Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasis.
    Ribeiro PAF; Vale DL; Dias DS; Lage DP; Mendonça DVC; Ramos FF; Carvalho LM; Carvalho AMRS; Steiner BT; Roque MC; Oliveira-da-Silva JA; Oliveira JS; Tavares GSV; Galvani NC; Martins VT; Chávez-Fumagalli MA; Roatt BM; Moreira RLF; Menezes-Souza D; Oliveira MC; Machado-de-Ávila RA; Teixeira AL; Coelho EAF
    Cytokine; 2020 May; 129():155031. PubMed ID: 32062145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvant.
    Schaut RG; Grinnage-Pulley TL; Esch KJ; Toepp AJ; Duthie MS; Howard RF; Reed SG; Petersen CA
    Vaccine; 2016 Oct; 34(44):5225-5234. PubMed ID: 27665354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasis.
    Dias DS; Ribeiro PAF; Martins VT; Lage DP; Ramos FF; Dias ALT; Rodrigues MR; Portela ÁSB; Costa LE; Caligiorne RB; Steiner BT; Chávez-Fumagalli MA; Salles BCS; Santos TTO; Silveira JAG; Magalhães-Soares DF; Roatt BM; Machado-de-Ávila RA; Duarte MC; Menezes-Souza D; Silva ES; Galdino AS; Coelho EAF
    Cell Immunol; 2018 Jan; 323():59-69. PubMed ID: 29128045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCG expressing LCR1 of Leishmania chagasi induces protective immunity in susceptible mice.
    Streit JA; Recker TJ; Donelson JE; Wilson ME
    Exp Parasitol; 2000 Jan; 94(1):33-41. PubMed ID: 10631078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-12 restores interferon-gamma production and cytotoxic responses in visceral leishmaniasis.
    Bacellar O; Brodskyn C; Guerreiro J; Barral-Netto M; Costa CH; Coffman RL; Johnson WD; Carvalho EM
    J Infect Dis; 1996 Jun; 173(6):1515-8. PubMed ID: 8648233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the immune response to Leishmania infantum recombinant antigens.
    de Carvalho LP; Soto M; Jerônimo S; Dondji B; Bacellar O; Luz V; Orge Orge G; Alonso C; Jesus AR; Carvalho EM
    Microbes Infect; 2003 Jan; 5(1):7-12. PubMed ID: 12593967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of immune biomarkers related to disease progression and treatment efficacy in human visceral leishmaniasis.
    Portela ÁSB; Costa LE; Salles BCS; Lima MP; Santos TTO; Ramos FF; Lage DP; Martins VT; Caligiorne RB; Lessa DR; Silva FR; Machado AS; Nascimento GF; Gama IS; Chávez-Fumagalli MA; Teixeira AL; Rocha MOC; Rocha RL; Coelho EAF
    Immunobiology; 2018 Mar; 223(3):303-309. PubMed ID: 29074301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with a CD4
    Dias DS; Ribeiro PAF; Martins VT; Lage DP; Costa LE; Chávez-Fumagalli MA; Ramos FF; Santos TTO; Ludolf F; Oliveira JS; Mendes TAO; Silva ES; Galdino AS; Duarte MC; Roatt BM; Menezes-Souza D; Teixeira AL; Coelho EAF
    Transl Res; 2018 Oct; 200():18-34. PubMed ID: 29908151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of HSP-70, KMP-11 and PFR-2 leishmanial antigens in the experimental model of canine visceral leishmaniasis.
    Carrillo E; Crusat M; Nieto J; Chicharro C; Thomas Mdel C; Martínez E; Valladares B; Cañavate C; Requena JM; López MC; Alvar J; Moreno J
    Vaccine; 2008 Mar; 26(15):1902-11. PubMed ID: 18321614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Non-pathogenic Recombinant Leishmania Expressing Lipophosphoglycan 3 Against Experimental Infection with Leishmania infantum.
    Pirdel L; Farajnia S
    Scand J Immunol; 2017 Jul; 86(1):15-22. PubMed ID: 28426153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human PBMC proliferative response to Leishmania infantum promastigotes is inhibited by anti-IFN-gamma mAb gamma 123.
    Zucca M; Novelli F; Giovarelli M; Caramello P; Garotta G; Musso T; Savoia D
    New Microbiol; 1995 Jan; 18(1):53-8. PubMed ID: 7760757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of T cell responses to purified leishmania antigens in subjects infected with Leishmania chagasi.
    Vinhas V; Freire M; Bacellar O; Cunha S; Rocha H; Carvalho EM
    Braz J Med Biol Res; 1994 May; 27(5):1199-205. PubMed ID: 8000341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmania infantum pyridoxal kinase evaluated in a recombinant protein and DNA vaccine to protects against visceral leishmaniasis.
    Oliveira-da-Silva JA; Lage DP; Ramos FF; Machado AS; Tavares GSV; Mendonça DVC; Pereira IAG; Martins VT; Carvalho LM; Ludolf F; Santos TTO; Reis TAR; Oliveira CS; Bandeira RS; Silva AM; Costa LE; Oliveira JS; Duarte MC; Menezes-Souza D; Roatt BM; Teixeira AL; Coelho EAF
    Mol Immunol; 2020 Aug; 124():161-171. PubMed ID: 32585510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasis.
    Oliveira-da-Silva JA; Machado AS; Ramos FF; Tavares GSV; Lage DP; Mendonça DVC; Pereira IAG; Santos TTO; Martins VT; Carvalho LM; Freitas CS; Ludolf F; Reis TAR; Bandeira RS; Silva AM; Costa LE; Oliveira JS; Duarte MC; Roatt BM; Teixeira AL; Coelho EAF
    Cell Immunol; 2020 Oct; 356():104194. PubMed ID: 32827943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs.
    Strauss-Ayali D; Baneth G; Shor S; Okano F; Jaffe CL
    Int J Parasitol; 2005 Jan; 35(1):63-73. PubMed ID: 15619517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.